Measures activity, not value. Not investment advice.
Quarterly revenue rose 94% to $83M, but the company lost $182.2M over 12 months.
BadShort interest 10% of shares, up 6.5% from two weeks earlier
WatchCapital spending rose 286% to $30.2M last quarter
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.
expected around 4 Mar 2027 (an estimate: a year ago it reported on 5 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $83.0M, net income $22.7M.
31 Dec 2021RevenueNet incomeNet losstallest bar $176.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$83.0M
$22.7M
30 Jun 2026
$46.5M
-$176.9M
31 Mar 2026
$42.9M
-$21.7M
31 Dec 2025
$45.3M
-$6.3M
30 Sep 2025
$42.7M
-$8.0M
30 Jun 2025
$43.4M
$2.1M
31 Mar 2025
$29.1M
-$21.7M
31 Dec 2024
$5.7M
-$17.6M
30 Sep 2024
$2.0M
-$21.2M
30 Jun 2024
$5.3M
-$21.0M
31 Mar 2024
$4.0M
-$18.9M
31 Dec 2023
$4.4M
-$18.5M
30 Sep 2023
$4.5M
-$15.7M
30 Jun 2023
$4.2M
-$14.4M
31 Mar 2023
$4.1M
-$17.6M
31 Dec 2022
$545K
-$25.4M
30 Sep 2022
$309K
-$43.8M
30 Jun 2022
$89K
-$13.2M
31 Mar 2022
$232K
-$15.7M
31 Dec 2021
$54K
-$16.5M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$217.8M
$120.9M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+80%
+6.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$182.2M
-$45.1M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.77
-$0.20
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
21.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-68.2%
-31.2%
2.7%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-83.7%
-37.3%
-1.0%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-47.5%
-4.9%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$30.8M
-$85.7M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$67.6M
$72.6M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$167.8M
$164.5M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$100.2M
$91.9M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.56
0.49
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$1.21
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
13.1
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.8
0.93
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
2.3
1.6
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
1.3
1.2
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
+$86K
bought $96K, sold $10K
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+9.0%
158 13F filers vs 145
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
34%
84.1M shares held by 13F filers (30 Sep 2026) of 247.4M outstanding (6 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
10%
24.9M shares sold short (30 Oct 2026) of 247.4M outstanding (6 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
8.4
24.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+6.5%
23.4M shares sold short in the report before, 24.9M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
47%
47% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
2
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+94%
$83.0M vs $42.7M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+286%
$30.2M vs $7.8M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$480K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
24
24 articles in the last 7 days; its usual week has 5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
4.8×
24 articles in the last 7 days; its usual week has 5.
Unusual now sharp changes in the last 90 days, compared with its own past
Revenue $83.0M, 1.9× a year earlier
Capital spending $30.2M, 3.9× a year earlier
Price $1.61 on 20 Nov 2026, -14% over 12 months (12-month range $1.11 to $2.77)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $2.5M in the last 12 months (the 12 months before: -$2.8M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.Revenue per quarter. Revenue $83.0M in the latest quarter, +94% on a year earlier.Capital spending per quarter. Capital spending $30.2M in the latest quarter, +286% on a year earlier.Institutional holders (13F filers). 158 13F filers reported holding it in the latest 13F quarter, +19% on a year earlier.Lobbying spend. Lobbying spend: $480K published in the last 12 months, -9.4% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $54K; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $232K, +149% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $89K, -79% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $309K, +118% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $545K, +909% on a year earlier; public on 10 Mar 2023
Quarter ended 31 Mar 2023: $4.1M, +1650% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $4.2M, +4662% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $4.5M, +1365% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $4.4M, +703% on a year earlier; public on 8 Mar 2024
Quarter ended 31 Mar 2024: $4.0M, -1.7% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $5.3M, +24% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $2.0M, -57% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $5.7M, +30% on a year earlier; public on 28 Mar 2025
Quarter ended 31 Mar 2025: $29.1M, +630% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $43.4M, +725% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $42.7M, +2074% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $45.3M, +696% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $42.9M, +48% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $46.5M, +7.1% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $83.0M, +94% on a year earlier; public on 11 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2022: $31.2M, +475% on a year earlier; public on 10 May 2022
Quarter ended 31 Mar 2023: $11.4M, -63% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $18.4M; public on 9 Aug 2024
Quarter ended 30 Sep 2023: $20.9M; public on 8 Nov 2024
Quarter ended 31 Mar 2024: $17.5M, +53% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $9.2M, -50% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $9.8M, -53% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $14.6M; public on 28 Mar 2025
Quarter ended 31 Mar 2025: $5.8M, -67% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $5.2M, -43% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $7.8M, -20% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $11.2M, -23% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $8.9M, +52% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $12.5M, +138% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $30.2M, +286% on a year earlier; public on 11 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 121; public on 14 Feb 2022
31 Mar 2022 report: 116; public on 16 May 2022
30 Jun 2022 report: 128; public on 15 Aug 2022
30 Sep 2022 report: 131; public on 14 Nov 2022
31 Dec 2022 report: 133; public on 14 Feb 2023
31 Mar 2023 report: 136; public on 15 May 2023
30 Jun 2023 report: 112; public on 14 Aug 2023
30 Sep 2023 report: 114; public on 14 Nov 2023
31 Dec 2023 report: 112; public on 14 Feb 2024
31 Mar 2024 report: 121; public on 15 May 2024
30 Jun 2024 report: 112; public on 14 Aug 2024
30 Sep 2024 report: 96; public on 14 Nov 2024
31 Dec 2024 report: 102; public on 14 Feb 2025
31 Mar 2025 report: 114; public on 15 May 2025
30 Jun 2025 report: 116; public on 14 Aug 2025
30 Sep 2025 report: 133; public on 14 Nov 2025
31 Dec 2025 report: 145; public on 17 Feb 2026
31 Mar 2026 report: 156; public on 15 May 2026
30 Jun 2026 report: 145; public on 14 Aug 2026
30 Sep 2026 report: 158; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $70K published
Quarter from 1 Apr 2022: $580K published
Quarter from 1 Jul 2022: $200K published
Quarter from 1 Oct 2022: $250K published
Quarter from 1 Apr 2023: $580K published
Quarter from 1 Jul 2023: $180K published
Quarter from 1 Oct 2023: $150K published
Quarter from 1 Jan 2024: $110K published
Quarter from 1 Apr 2024: $90K published
Quarter from 1 Jul 2024: $100K published
Quarter from 1 Oct 2024: $100K published
Quarter from 1 Jan 2025: $110K published
Quarter from 1 Apr 2025: $160K published
Quarter from 1 Jul 2025: $150K published
Quarter from 1 Oct 2025: $110K published
Quarter from 1 Jan 2026: $150K published
Quarter from 1 Apr 2026: $150K published
Quarter from 1 Jul 2026: $110K published
Quarter from 1 Oct 2026: $70K published
What is unusual now
Made public in the last 90 days: it reported revenue of $83.0M for the quarter ended 30 Sep 2026, 1.9× the same quarter last year; it also spent $30.2M on capital projects in the quarter ended 30 Sep 2026, 3.9× the same quarter last year.
Quarterly revenue change: reported revenue of $83.0M for the quarter ended 30 Sep 2026, 1.9× the same quarter last year Public on 12 Nov 2026.
Quarterly capital spending jump: spent $30.2M on capital projects in the quarter ended 30 Sep 2026, 3.9× the same quarter last year Public on 12 Nov 2026.
Reported lobbying spend: $70K in Q3 2026, $110K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
30 Jun 2026
Ended
Boundary Stone Partnersfor Gevo
Department of Energy Loan Programs OfficeEnergy, Manufacturing
Issues related to the reduction of greenhouse gas emissions; development and use of sustainable aviation fuel, renewable premium gasoline, and renewable natural gas; tax credits for renewable energy; Section 45Q carbon capture and sequestration tax credits; Clean Air Act (Renewable Fuel Standard); sAgriculture, Taxation, Environment, Aviation, Energy, FUE, CAW
Tax credits for renewable energy, sustainable aviation fuels, and biofuels H.R.5376 - Build Back Better Act, issues related to renewable energy tax credits Issues related to the development and use of sustainable aviation fuel Amendments to the Clean Air Act regarding fuel standards and biodieselEnergy, FUE
Funding for DOD testing of biologically derived jet fuel for defense purposes.; MOU between USDA/DOE/Navy Department on use of Defense Production Act to incentivize biofuels production; continuation of tax credit for non-ethanol alcohol fuels; EPA commingling draft rule to allow non-ethanol biofuels to enter the marketplace.Defense, Energy
Two or more unrelated kinds of records unusual within 30 days
10 Mar 2026confirmed
Confirmed across sources Filings + Financials and Lobbying
Gevo(GEVO): lobbying on a new issue, while it reported revenue of $45.3M for the quarter ended 31 Dec 2025, 8.0× the same quarter last year. Two unrelated kinds of activity within 27 days.
Lobbying: Lobbying on a new issue, became public on 11 Feb 2026
Financials: Quarterly revenue change, became public on 10 Mar 2026
The quarter ended 31 Dec 2025 against the 8 quarters before it.
this quarterearliernormal: $5.5MSee the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 11 Feb 2026
Gevo lobbying on a new issue.
New
['TRD']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4688608
Financials: Quarterly revenue change became public on 10 Mar 2026
Gevo reported revenue of $45.3M for the quarter ended 31 Dec 2025, 8.0× the same quarter last year.
This period
$45.3M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$5.5M
Typical spread (median absolute deviation)
$2.5M
How far from its usual level
+10.7
Same quarter last year
$5.7M
History used
5,663 days
the quarter ended 31 Dec 20258 earlier quartersnormal: $5.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
15 May 2025confirmed
Confirmed across sources Filings + Financials and Lobbying
Gevo(GEVO): lobbying on a new issue, while it reported revenue of $29.1M for the quarter ended 31 Mar 2025, 7.3× the same quarter last year. Two unrelated kinds of activity within 24 days.
Lobbying: Lobbying on a new issue, became public on 21 Apr 2025
Financials: Quarterly revenue change, became public on 15 May 2025
The quarter ended 31 Mar 2025 against the 8 quarters before it.
this quarterearliernormal: $4.3MSee the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 21 Apr 2025
Gevo lobbying on a new issue.
New
['MAN']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
6138948
Financials: Quarterly revenue change became public on 15 May 2025
Gevo reported revenue of $29.1M for the quarter ended 31 Mar 2025, 7.3× the same quarter last year.
This period
$29.1M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$4.3M
Typical spread (median absolute deviation)
$281K
How far from its usual level
+24.8
Same quarter last year
$4.0M
History used
3,287 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $4.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
16 Aug 2022confirmed
Confirmed across sources Lobbying and Short interest and volume
Gevo(GEVO): reported $200K of lobbying spend for the quarter ended 30 Jun 2022, 10× the same quarter last year, while it had 54.3M shares sold short in the 29 Jul 2022 report, 2.2× the same report last year. Two unrelated kinds of activity within 21 days.
Lobbying: Lobbying spend jump, became public on 20 Jul 2022
Short interest and volume: Short interest spike, became public on 10 Aug 2022
The quarter ended 30 Jun 2022 against the 8 quarters before it.
this quarterearliernormal: $20KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 20 Jul 2022
Gevo reported $200K of lobbying spend for the quarter ended 30 Jun 2022, 10× the same quarter last year.
This period
$200K (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$20K
Typical spread (median absolute deviation)
$0
How far from its usual level
+9.0
Same quarter last year
$20K
History used
4,474 days
the quarter ended 30 Jun 20228 earlier quartersnormal: $20K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Short interest and volume: Short interest spike became public on 10 Aug 2022
Gevo had 54.3M shares sold short in the 29 Jul 2022 report, 2.2× the same report last year.
This period
54.3M (the 29 Jul 2022 report)
Normal report (median of 24 earlier)
34.9M
Typical spread (median absolute deviation)
3.6M
How far from its usual level
+3.6
Same report last year
25.1M
History used
1,673 days
the 29 Jul 2022 report24 earlier reportsnormal: 34.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
12 Nov 2026Financials change
reported revenue of $83.0M for the quarter ended 30 Sep 2026, 1.9× the same quarter last year.
Same quarter last year: $42.7M; its normal quarter is $42.8M.
See the evidence
This period
$83.0M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$42.8M
Typical spread (median absolute deviation)
$3.1M
How far from its usual level
+8.7
Same quarter last year
$42.7M
History used
3,835 days
the quarter ended 30 Sep 20268 earlier quartersnormal: $42.8M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
spent $30.2M on capital projects in the quarter ended 30 Sep 2026, 3.9× the same quarter last year.
Same quarter last year: $7.8M; its normal quarter is $9.3M.
See the evidence
This period
$30.2M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$9.3M
Typical spread (median absolute deviation)
$2.5M
How far from its usual level
+5.6
Same quarter last year
$7.8M
History used
3,835 days
the quarter ended 30 Sep 20268 earlier quartersnormal: $9.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
lobbying on a new issue, while it reported revenue of $45.3M for the quarter ended 31 Dec 2025, 8.0× the same quarter last year. Two unrelated kinds of activity within 27 days.
See the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 11 Feb 2026
Gevo lobbying on a new issue.
New
['TRD']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
4688608
Financials: Quarterly revenue change became public on 10 Mar 2026
Gevo reported revenue of $45.3M for the quarter ended 31 Dec 2025, 8.0× the same quarter last year.
This period
$45.3M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$5.5M
Typical spread (median absolute deviation)
$2.5M
How far from its usual level
+10.7
Same quarter last year
$5.7M
History used
5,663 days
the quarter ended 31 Dec 20258 earlier quartersnormal: $5.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
10 Mar 2026Financials change
reported revenue of $45.3M for the quarter ended 31 Dec 2025, 8.0× the same quarter last year.
Same quarter last year: $5.7M; its normal quarter is $5.5M.
See the evidence
This period
$45.3M (the quarter ended 31 Dec 2025)
Normal quarter (median of 8 earlier)
$5.5M
Typical spread (median absolute deviation)
$2.5M
How far from its usual level
+10.7
Same quarter last year
$5.7M
History used
5,663 days
the quarter ended 31 Dec 20258 earlier quartersnormal: $5.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $42.7M for the quarter ended 30 Sep 2025, 22× the same quarter last year.
Same quarter last year: $2.0M; its normal quarter is $4.9M.
See the evidence
This period
$42.7M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$4.9M
Typical spread (median absolute deviation)
$855K
How far from its usual level
+29.8
Same quarter last year
$2.0M
History used
5,571 days
the quarter ended 30 Sep 20258 earlier quartersnormal: $4.9M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $43.4M for the quarter ended 30 Jun 2025, 8.3× the same quarter last year.
Same quarter last year: $5.3M; its normal quarter is $4.5M.
See the evidence
This period
$43.4M (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
$4.5M
Typical spread (median absolute deviation)
$635K
How far from its usual level
+39.0
Same quarter last year
$5.3M
History used
5,479 days
the quarter ended 30 Jun 20258 earlier quartersnormal: $4.5M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
lobbying on a new issue, while it reported revenue of $29.1M for the quarter ended 31 Mar 2025, 7.3× the same quarter last year. Two unrelated kinds of activity within 24 days.
See the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 21 Apr 2025
Gevo lobbying on a new issue.
New
['MAN']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
6138948
Financials: Quarterly revenue change became public on 15 May 2025
Gevo reported revenue of $29.1M for the quarter ended 31 Mar 2025, 7.3× the same quarter last year.
This period
$29.1M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$4.3M
Typical spread (median absolute deviation)
$281K
How far from its usual level
+24.8
Same quarter last year
$4.0M
History used
3,287 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $4.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
15 May 2025Financials change
reported revenue of $29.1M for the quarter ended 31 Mar 2025, 7.3× the same quarter last year.
Same quarter last year: $4.0M; its normal quarter is $4.3M.
See the evidence
This period
$29.1M (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
$4.3M
Typical spread (median absolute deviation)
$281K
How far from its usual level
+24.8
Same quarter last year
$4.0M
History used
3,287 days
the quarter ended 31 Mar 20258 earlier quartersnormal: $4.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Showing the newest 40 of 121 entries; narrow the window or the kind of data to see older ones.
Not listed: 387 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001392380
Ticker
GEVO
Domain
gevo.com
Employer name
Gevo, Inc. (1 unverified)
Fein
87-0747704 (1 unverified)
Hq location
CO|ENGLEWOOD|80112 (1 unverified)
Lobbying client
gevo
Name
Cultivate Agricultural Intelligence, LLC, Gevo Asset, LLC, Gevo, Inc., Gevo Intermediate HoldCo, LLC and 14 more
Wikidata
Q5554922
Wikipedia
Gevo
DOL H-1B labor condition applications and PERM certifications5 data points24 Feb 2025 to 24 Feb 2025
Federal lobbying disclosures (LDA)7 records, 144 data points30 Jun 2009 to 30 Sep 2026
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)221 records22 Jan 2016 to 10 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1115 data points31 Dec 2005 to 6 Nov 2026
SEC Form 4 insider transactions225 records, 368 data points6 Jan 2016 to 4 Sep 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
Wikipedia pageviews2820 data points1 Jan 2019 to 21 Nov 2026